Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partner Brent Babcock Discusses New CRISPR IP Alliance

December 19, 2016  | Brenton R. Babcock

Partner Brent Babcock, Chair of the firm’s USPTO Trials & Post-Grant Proceedings group, was quoted in “Some Consensus in the CRISPR Patent Case,” an article published in MedCity News. The article discuses four companies founded in the CRISPR space that announced last Friday, December 16, that they had formed an IP alliance.

Read the article here

 

Related Links

Industries

News & Insights

Blog - Biotechnology
Dec 2025
Life Science Considerations on the USPTO’s New Guidelines for AI-Assisted Inventorship
On November 26, 2025, the United States Patent and Trademark Office (USPTO) issued revised guidelines for determining inventorship of AI-assisted inventions,[1] which is a significant development in life science innovations,...
News
Dec 2025
Jonathan Menkes Discusses AI and Copyright Regulations in Interview with The Register
In a recent interview with enterprise technology news publication The Register, partner Jonathan Menkes offered his insights on the evolving landscape of artificial intelligence and copyright infringement. Menkes shared how...
Blog - Aerospace
Dec 2025
FAA Request for Information Related to a New Air Traffic Control Platform
The Federal Aviation Administration (FAA) issued a request for information (RFI) related to “a single, state-of-the art platform for air traffic control called the Common Automation Platform (CAP).” The CAP...